BIOMAY AG
🇦🇹Austria
Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response
Phase 2
Completed
- Conditions
- Hypersensitivity
- Interventions
- Biological: BM32Biological: Placebo
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 130
- Registration Number
- NCT02643641
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
Phase II Study of Grass Pollen Allergy Vaccine BM32
Phase 2
Completed
- Conditions
- Grass Pollen Allergy
- Interventions
- Biological: BM32Biological: Placebo
- First Posted Date
- 2012-02-27
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 181
- Registration Number
- NCT01538979
- Locations
- 🇩🇪
Department of Dermatology and Allergology Am Biederstein TU Munich, Munich, Bavaria, Germany
🇦🇹Medical University, Vienna, Austria
🇧🇪Allergy Network Ghent University Hospital Ghent, Dept. Otorhiolaryngologie, Ghent, Belgium
Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy
Phase 2
Completed
- Conditions
- Grass Pollen Allergy
- Interventions
- Biological: BM32Biological: Placebo
- First Posted Date
- 2011-10-03
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 79
- Registration Number
- NCT01445002
- Locations
- 🇦🇹
Allergy Center Vienna West, Vienna, Austria
Skin Test Study of BM32
Phase 1
Completed
- Conditions
- Hypersensitivity
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 60
- Registration Number
- NCT01350635
- Locations
- 🇦🇹
Medical University, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath